Latest filing published 20 Mar 2024 for Biohit Oyj, €20k.
All filings by Jussi Hahtela on record concern Biohit Oyj, in the capacity of chief executive. The record holds 2 filings, for trades running from 20 March 2023 to 18 March 2024.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 20 March 2024, the filings show a transaction worth €20k in Biohit Oyj. These figures are compiled from regulatory filings published by Nasdaq Helsinki. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations